Chun-Nan Yeh Selected Research

Sarcoma (Soft Tissue Sarcoma)

1/2023	Marked Response to Larotrectinib in Pelvic Spindle Cell Sarcoma With Concurrent TPM3-NTRK1 Fusion and CDK4/MDM2 Amplification: A Case Report.
1/2013	Gene expression-based chemical genomics identifies heat-shock protein 90 inhibitors as potential therapeutic drugs in cholangiocarcinoma.
10/2012	Integrating bioinformatics and clinicopathological research of gastrointestinal stromal tumors: identification of aurora kinase A as a poor risk marker.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chun-Nan Yeh Research Topics

Disease

110	Neoplasms (Cancer) 04/2024 - 09/2002
35	Cholangiocarcinoma 12/2023 - 04/2004
34	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2022 - 04/2006
20	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2005
9	Hepatocellular Carcinoma (Hepatoma) 06/2023 - 07/2002
9	Carcinogenesis 01/2023 - 04/2004
9	Breast Neoplasms (Breast Cancer) 01/2021 - 06/2002
8	Wounds and Injuries (Trauma) 12/2023 - 01/2014
8	Biliary Tract Neoplasms (Biliary Tract Cancer) 10/2023 - 01/2019
8	Hypercalcemia (Milk Alkali Syndrome) 01/2016 - 12/2011
6	Acute Cholecystitis 11/2022 - 01/2020
6	Adenocarcinoma 01/2022 - 02/2010
6	Stomach Neoplasms (Stomach Cancer) 01/2020 - 10/2009
5	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021 - 07/2016
5	Margins of Excision 11/2018 - 09/2002
5	Carcinoma (Carcinomatosis) 07/2014 - 03/2004
5	Pain (Aches) 05/2014 - 05/2004
4	Thyroid Neoplasms (Thyroid Cancer) 12/2023 - 06/2017
4	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 12/2016
4	Necrosis 02/2022 - 11/2006
4	Disease Progression 01/2022 - 06/2011
4	Postoperative Pain 01/2021 - 05/2009
4	Lymphatic Metastasis 01/2015 - 01/2009
3	Anaplastic Thyroid Carcinoma 04/2024 - 12/2015
3	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2023 - 10/2020
3	Fistula 01/2023 - 02/2006
3	Sarcoma (Soft Tissue Sarcoma) 01/2023 - 10/2012
3	Hemorrhage 02/2022 - 09/2007
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 11/2014
3	Hepatitis B 01/2021 - 07/2005
3	Infections 01/2020 - 04/2005
3	Brain Neoplasms (Brain Tumor) 03/2016 - 01/2014
3	Liver Cirrhosis (Hepatic Cirrhosis) 09/2015 - 12/2002
3	Chronic Kidney Failure (Chronic Renal Failure) 04/2015 - 04/2005
3	Pancreatic Neoplasms (Pancreatic Cancer) 11/2014 - 01/2011

Drug/Important Bio-Agent (IBA)

25	Imatinib Mesylate (Gleevec)FDA Link 01/2022 - 04/2006
15	Proteins (Proteins, Gene)FDA Link 12/2023 - 07/2007
15	hydroxide ionIBA 07/2018 - 12/2011
15	Vitamin D FDA LinkGeneric 01/2017 - 01/2011
14	19- nor- 2- (3- hydroxypropyl)- 1,25- dihydroxyvitamin D3IBA 07/2018 - 12/2011
11	Gemcitabine FDA Link 10/2023 - 08/2016
11	Sunitinib (Sutent)FDA Link 01/2022 - 04/2011
10	regorafenibIBA 12/2023 - 03/2016
10	Thioacetamide (Thioacetamid)IBA 01/2022 - 04/2004
8	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 03/2006
7	AntigensIBA 01/2023 - 12/2007
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2014
6	CarbohydratesIBA 01/2023 - 05/2012
5	EnzymesIBA 01/2023 - 04/2013
5	AlbuminsIBA 01/2022 - 04/2003
5	Alkaline PhosphataseIBA 06/2021 - 12/2002
4	RNA (Ribonucleic Acid)IBA 12/2023 - 09/2018
4	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 12/2023 - 04/2006
4	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2020
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 03/2016
4	fenbufenIBA 12/2017 - 04/2013
4	AmidesIBA 03/2016 - 04/2013
4	Capsules (Microcapsules)IBA 04/2004 - 09/2002
3	Phosphotransferases (Kinase)IBA 12/2023 - 04/2006
3	Everolimus FDA Link 12/2023 - 01/2019
3	palbociclibIBA 12/2023 - 09/2018
3	Tyrosine Kinase InhibitorsIBA 12/2023 - 01/2019
3	Globo-HIBA 06/2023 - 01/2022
3	MucinsIBA 01/2023 - 03/2009
3	Hemoglobins (Hemoglobin)IBA 02/2022 - 04/2005
3	DNA VaccinesIBA 01/2022 - 12/2007
3	Therapeutic UsesIBA 01/2022 - 06/2017
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 07/2021 - 01/2015
3	Cisplatin (Platino)FDA LinkGeneric 07/2021 - 07/2014
3	Protein Isoforms (Isoforms)IBA 07/2021 - 04/2006
3	Hormones (Hormone)IBA 01/2021 - 01/2012
3	Messenger RNA (mRNA)IBA 11/2020 - 02/2009
3	Aurora Kinase AIBA 09/2018 - 10/2012
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 06/2017 - 01/2013
3	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2017 - 06/2014
3	Urea (Carbamide)FDA LinkGeneric 08/2009 - 04/2003
3	NitrogenIBA 08/2009 - 04/2003
2	ErbB Receptors (EGF Receptor)IBA 12/2023 - 01/2011
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2023 - 12/2023
2	CeramidesIBA 01/2023 - 01/2022
2	InterferonsIBA 01/2023 - 01/2019
2	Cancer VaccinesIBA 01/2022 - 11/2020
2	GSK2830371IBA 01/2022 - 07/2021
2	ripretinibIBA 01/2022 - 01/2022
2	MicroRNAs (MicroRNA)IBA 09/2021 - 01/2020

Therapy/Procedure

31	Therapeutics 12/2023 - 07/2005
15	Hepatectomy 03/2022 - 12/2002
12	Drug Therapy (Chemotherapy) 01/2023 - 06/2004
8	Radiotherapy 01/2019 - 03/2005
7	Gastrectomy 08/2020 - 10/2009
6	Cholecystectomy 11/2022 - 02/2006
6	Laparotomy 08/2020 - 07/2002
5	Pancreaticoduodenectomy 01/2022 - 11/2005
4	Cholecystostomy 09/2021 - 08/2020
4	Laparoscopic Cholecystectomy 01/2018 - 03/2004
3	Immunotherapy 01/2023 - 12/2007
3	Adjuvant Chemotherapy 01/2020 - 02/2010
3	Contraindications 08/2009 - 04/2005
3	Length of Stay 01/2007 - 01/2002
2	Precision Medicine 01/2022 - 01/2021